Mounjaro (tirzepatide) and Ozempic (semaglutide) are both once weekly injectable medications approved for type 2 diabetes that also lead to significant weight loss, but Mounjaro targets two gut hormones (GLP-1 and GIP) while Ozempic targets only one (GLP-1), and clinical trials suggest Mounjaro may produce greater reductions in blood sugar and body weight on average.

Key Takeaways

  • Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist, while Ozempic (semaglutide) is a single GLP-1 receptor agonist.
  • In head to head trials, Mounjaro led to greater A1C reductions and more weight loss than Ozempic over 40 and 52 weeks.
  • Both medications have similar side effects, including nausea, vomiting, and diarrhea, but Mounjaro may cause slightly more gastrointestinal issues at higher doses.
  • Ozempic has longer term cardiovascular outcome data showing reduced risk of heart attack and stroke, while Mounjaro’s cardiovascular data is still emerging.
  • The choice between them depends on individual health goals, insurance coverage, and how your body responds to each medication.

What Are the Main Differences Between Mounjaro and Ozempic?

The primary difference is how each drug works in your body. Ozempic contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone that helps regulate appetite and insulin release. Mounjaro contains tirzepatide, which activates both GLP-1 receptors and GIP receptors. GIP is another hormone that helps the body use sugar more effectively and may further reduce appetite. This dual action is why researchers believe Mounjaro may be more potent for both blood sugar control and weight loss.

Which Medication Leads to More Weight Loss?

Clinical trials indicate that Mounjaro generally leads to greater weight loss than Ozempic. In a 40 week study published in the New England Journal of Medicine, people taking the highest dose of Mounjaro lost an average of 15 to 20 pounds more than those taking the highest dose of Ozempic. Another study found that after one year, about half of people on Mounjaro lost at least 15 percent of their body weight, compared to about one quarter of those on Ozempic. However, individual results vary, and some people respond better to one medication than the other.

How Do They Compare for Blood Sugar Control?

Both medications effectively lower blood sugar, but Mounjaro has shown superior results in direct comparisons. In the SURPASS 2 trial, people taking Mounjaro 5 mg, 10 mg, or 15 mg experienced greater reductions in A1C than those taking Ozempic 1 mg. For example, the highest dose of Mounjaro lowered A1C by about 2.3 percentage points from baseline, compared to about 1.9 percentage points for Ozempic. More people on Mounjaro also achieved an A1C below 5.7 percent, which is considered normal.

What Are the Side Effects of Each Drug?

Side effects are similar for both medications because they both affect the digestive system. The most common issues include nausea, vomiting, diarrhea, constipation, and abdominal pain. These tend to be worse when starting treatment or increasing the dose. Some studies suggest that Mounjaro may cause slightly more nausea and diarrhea at higher doses, but the difference is small. Both drugs carry a warning about a rare risk of thyroid tumors and pancreatitis. You should not take either if you have a personal or family history of medullary thyroid carcinoma.

Which Has Better Long Term Safety Data?

Ozempic has more long term safety data, especially regarding heart health. The SUSTAIN 6 trial showed that semaglutide reduced the risk of major cardiovascular events like heart attack and stroke by 26 percent in people with type 2 diabetes and heart disease. Mounjaro’s cardiovascular outcomes trial, called SURPASS CVOT, is still ongoing, and results are expected in the next few years. For now, if you have established heart disease, your doctor may prefer Ozempic based on the available evidence.

How Are They Dosed and Administered?

Both medications are injectable and given once weekly. Ozempic is available in a prefilled pen with doses of 0.25 mg, 0.5 mg, 1 mg, and 2 mg. Mounjaro comes in a single dose vial or prefilled pen with doses of 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. Both require gradual dose escalation to reduce side effects. For example, you start Ozempic at 0.25 mg for four weeks before increasing. Mounjaro starts at 2.5 mg for four weeks. The maximum approved dose for Ozempic is 2 mg weekly, while Mounjaro goes up to 15 mg weekly.

Which Is More Affordable or Covered by Insurance?

Cost and insurance coverage vary widely. Both medications are brand name and expensive without insurance, often costing over 900 dollars per month. Most insurance plans cover both for type 2 diabetes, but coverage for weight loss is limited. Ozempic is sometimes preferred by insurers because it has been on the market longer and has more generic competition expected soon. Mounjaro may have higher out of pocket costs if your plan does not cover it. Patient assistance programs are available from both manufacturers for eligible people.

Can You Switch From Ozempic to Mounjaro or Vice Versa?

Yes, but switching should be done under medical supervision. If you switch from Ozempic to Mounjaro, your doctor will typically start you at the lowest Mounjaro dose (2.5 mg) regardless of your Ozempic dose. This helps minimize side effects. The same applies if switching from Mounjaro to Ozempic. There is no direct dose equivalency between the two drugs, so you cannot simply swap one dose for another. Your doctor will monitor your blood sugar and side effects during the transition.

Which Is Better for Weight Loss Without Diabetes?

Neither medication is currently approved by the FDA for weight loss in people without diabetes. However, a higher dose version of semaglutide called Wegovy is approved for weight loss. Mounjaro is also being studied for weight loss under the name tirzepatide, and a separate approval for weight management is expected. Some doctors prescribe Mounjaro or Ozempic off label for weight loss, but this is not recommended without discussing risks and insurance limitations. For people without diabetes, Wegovy or other approved weight loss medications may be more appropriate.

For a deeper look at how these medications function, read our guide on GLP-1 Medications Explained.

Frequently Asked Questions

Is Mounjaro stronger than Ozempic?

In clinical trials, Mounjaro has shown greater reductions in A1C and more weight loss compared to Ozempic. This is likely because Mounjaro activates two hormone receptors instead of one. However, “stronger” does not always mean better for every person. Some people experience more side effects with Mounjaro or may not respond as well. Your doctor can help determine which medication is likely to work best based on your health profile and treatment goals.

Can I take Mounjaro and Ozempic together?

No, you should not take Mounjaro and Ozempic together. Both medications work through similar pathways and combining them would increase the risk of severe side effects like dangerously low blood sugar, nausea, vomiting, and pancreatitis. If you are considering switching from one to the other, talk to your doctor about a proper transition plan. Never take both at the same time.

Which medication has fewer gastrointestinal side effects?

Both medications cause similar gastrointestinal side effects, but some studies suggest that Ozempic may have a slightly lower rate of nausea and diarrhea at comparable effective doses. However, the difference is modesthol. The best way to minimize side effects with either drug is to start at the lowest dose, increase slowly, and take the injection with food if nausea occurs. If side effects are severe, your doctor may adjust the dose or consider switching to the other medication.

This article is for general information and is not medical advice. See our Medical Disclaimer.